Back to search
FDAFDA · Food and drugs·Recall number D-0080-2023

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.

Published December 21, 2022 · Recall initiated: November 28, 2022

Summary

FDA records drug Class I recall D-0080-2023, published December 21, 2022 and initiated November 28, 2022. Recalling firm: Exela Pharma Sciences LLC; Status: Terminated; Reported quantity: 37,320 vials; Lot: Lot: P0001490 Exp. 12/2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Exela Pharma Sciences LLC
Distributor
Nationwide within the United States
Lot
Lot: P0001490 Exp. 12/2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1. recalled?

Yes. FDA published recall D-0080-2023 on December 21, 2022. Reported hazard: Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release